NASDAQ:ZYXI - Nasdaq - US98986M1036 - Common Stock - Currency: USD
7.19
-0.22 (-2.97%)
The current stock price of ZYXI is 7.19 USD. In the past month the price decreased by -13.16%. In the past year, price decreased by -44.31%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,100 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
ZYNEX INC
9655 Maroon Circle
Englewood COLORADO 80112 US
CEO: Thomas Sandgaard
Employees: 1100
Company Website: https://www.zynex.com/
Investor Relations: https://zynexmed.investorroom.com/
Phone: 18004956670
The current stock price of ZYXI is 7.19 USD. The price decreased by -2.97% in the last trading session.
The exchange symbol of ZYNEX INC is ZYXI and it is listed on the Nasdaq exchange.
ZYXI stock is listed on the Nasdaq exchange.
9 analysts have analysed ZYXI and the average price target is 17.85 USD. This implies a price increase of 148.26% is expected in the next year compared to the current price of 7.19. Check the ZYNEX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ZYNEX INC (ZYXI) has a market capitalization of 229.00M USD. This makes ZYXI a Micro Cap stock.
ZYNEX INC (ZYXI) currently has 1100 employees.
ZYNEX INC (ZYXI) has a resistance level at 7.5. Check the full technical report for a detailed analysis of ZYXI support and resistance levels.
The Revenue of ZYNEX INC (ZYXI) is expected to grow by 4.43% in the next year. Check the estimates tab for more information on the ZYXI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ZYXI does not pay a dividend.
ZYNEX INC (ZYXI) will report earnings on 2025-02-27, after the market close.
The PE ratio for ZYNEX INC (ZYXI) is 22.47. This is based on the reported non-GAAP earnings per share of 0.32 and the current share price of 7.19 USD. Check the full fundamental report for a full analysis of the valuation metrics for ZYXI.
The outstanding short interest for ZYNEX INC (ZYXI) is 29.19% of its float. Check the ownership tab for more information on the ZYXI short interest.
ChartMill assigns a fundamental rating of 7 / 10 to ZYXI. ZYXI gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months ZYXI reported a non-GAAP Earnings per Share(EPS) of 0.32. The EPS decreased by -25.58% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.49% | ||
ROA | 3.83% | ||
ROE | 13.49% | ||
Debt/Equity | 1.66 |
ChartMill assigns a Buy % Consensus number of 84% to ZYXI. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -53.64% and a revenue growth 4.43% for ZYXI